Stable overexpression of Pregnane X receptor in HepG2 cells increases its potential for bioartificial liver application
Geert A. A. Nibourg, Maarten T. Huisman, Tessa V. van der Hoeven, Thomas M. van Gulik, Robert A. F. M. Chamuleau, Ruurdtje Hoekstra – 30 August 2010 – To bridge patients with acute liver failure to transplantation or liver regeneration, a bioartificial liver (BAL) is urgently needed. A BAL consists of an extracorporeal bioreactor loaded with a bioactive mass that would preferably be of human origin and display high hepatic functionality, including detoxification. The human hepatoma cell line HepG2 exhibits many hepatic functions, but its detoxification function is low.